Comparative Pharmacology
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus ZIPSOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus ZIPSOR.
ADVIL DUAL ACTION WITH ACETAMINOPHEN vs ZIPSOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. Acetaminophen is an analgesic and antipyretic whose mechanism is not fully understood but involves inhibition of cyclooxygenase in the central nervous system and modulation of the endocannabinoid system.
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis involved in inflammation, pain, and fever. It has no significant inhibition of COX-1 at therapeutic doses.
One caplet (ibuprofen 250 mg and acetaminophen 500 mg) orally every 8 hours while symptoms persist; maximum: 3 caplets per day.
50 mg orally three times daily
None Documented
None Documented
Ibuprofen: 2-4 hours; Acetaminophen: 2-3 hours. Clinical context: Short half-lives require dosing every 6-8 hours. Extended half-life in overdose (acetaminophen >4 hours indicates toxicity).
2-4 hours (terminal); clinical context: short half-life necessitates frequent dosing for sustained relief; prolonged in hepatic impairment
Ibuprofen: renal (90% as metabolites and conjugates, <10% unchanged); Acetaminophen: renal (85% as sulfate and glucuronide conjugates, 4% unchanged, 9% as cysteine and mercapturic acid conjugates; minor biliary).
Renal: ~60% unchanged; biliary/fecal: ~30% as metabolites; remainder as glucuronide conjugates
Category C
Category C
NSAID/Analgesic Combination
NSAID